Company news
Lexington Biosciences Inc news in 2018
Lexington Biosciences Inc's news releases, calls and decks from 2018, newest first.
Lexington Announces Q3 2018 Financial Results and Non-Brokered Private Placement
November 29, 2018
Lexington Provides Q3 Corporate Review
October 23, 2018
Lexington Announces Non-Brokered Private Placement
August 27, 2018
Lexington Announces First Multicenter Clinical Study Site
August 21, 2018
Lexington Biosciences Receives HeartSentry USPTO Patent Approval
July 25, 2018
Lexington Biosciences Announces Results of Annual General Meeting
July 2, 2018
Lexington Biosciences Concludes Initial HeartSentry Clinical Study
June 27, 2018
Lexington Biosciences Announces Amended Terms to Previously Announced Brokered Financing
June 11, 2018
Lexington Engages with Major Canadian University and Provides Clinical Trial Update
May 8, 2018
Lexington Announces Brokered Private Placement
May 4, 2018
Lexington Releases Audited Consolidated Financial Statements
April 30, 2018
Lexington Cardiovascular Health Monitor Performing as Designed with First Clinical Patients
March 5, 2018
Lexington Begins HeartSentry Clinical Trial
February 20, 2018
Lexington Delivers 1st Generation HeartSentry for Clinical Trials
February 13, 2018
Lexington Recieves Approval to Commence Clinical Study
January 24, 2018
Lexington Completes IRB Submission in Preparation for Clinical Study
January 18, 2018
Lexington Biosciences Announces Exercise of Warrants
January 11, 2018